Read the latest positive news, breakthroughs, and inspiring stories about muscular dystrophy, curated daily by BrightWire.
Scientists at Penn Medicine discovered that a chromosome-protecting protein also helps muscle stem cells maintain their ability to repair damaged tissue. Without this protein, injured muscles turn to fat and scar tissue instead of healing.
Scientists discovered that a chromosome-protecting protein also helps muscle stem cells maintain their ability to heal injuries, offering new hope for treating muscular dystrophy. Without this protein, damaged muscle turns to fat and scar tissue instead of rebuilding properly.
Mike Sciotti crawled 11.3 miles on his hands and knees in 1978 to raise money for muscular dystrophy. Nearly five decades later, his college returned to honor the world record that almost nobody remembered.
The Muscular Dystrophy Association's annual conference brings together scientists and advocates to share breakthroughs that could change lives. Registration is now open for the March 2027 event, where cutting-edge research meets real-world hope.
A groundbreaking treatment that switches off a faulty gene is showing early success in 12 people with a rare form of muscular dystrophy. Instead of losing muscle as expected, patients are gaining strength.
A groundbreaking RNA therapy just succeeded in early trials for a rare muscular dystrophy affecting thousands, and it could become the first treatment that actually modifies the disease's progression. Novartis's del-brax showed clear signs of reducing muscle damage in patients with facioscapulohumeral muscular dystrophy.
After a difficult year, biotech company Sarepta Therapeutics is bouncing back with early clinical trial results showing two new muscular dystrophy treatments appear safe and effective. The promising data offers hope for patients with rare muscle-wasting diseases who desperately need new treatment options.
A nonprofit and patient foundation just committed $7.65 million to develop a gene therapy for a rare muscular dystrophy with no current treatments. The partnership will take the therapy from initial design all the way to human clinical trials.
Boys with Duchenne muscular dystrophy are showing sustained improvements three years after receiving Elevidys gene therapy, demonstrating the treatment can slow progression of this muscle-wasting disease. The results offer hope to families facing a condition that typically causes rapid physical decline around age 9.
Scientists in Japan have discovered that simple iron supplements can significantly improve muscle strength in mice with a rare form of muscular dystrophy, offering hope for thousands of patients with no current treatment options. The breakthrough works by correcting iron imbalances in muscle tissue, not by fixing the underlying genetic cause.
A South Korean teen with muscular dystrophy can now lift his arms with ease thanks to a revolutionary shirt that weighs less than two pounds. The wearable exoskeleton costs thousands less than traditional models and could restore independence to millions.
Scientists at Carnegie Mellon University have discovered a breakthrough approach to target the root cause of myotonic dystrophy type 1, the most common form of adult muscular dystrophy. The precision therapy could finally offer hope to patients with a disease that currently has no effective treatment.